All those science discussions are boring, wannabe in nature and just distraction, wasting time and doing no good for any investors.
MOA of DCVax-L is clear and easy to understand; we have had some clinical data, including the recent publication about still blinded data.
Nobody in the history of drug/vaccine/treatment developments has ever managed to predict outcomes of a blinded trial correctly, if not by chance once or two or by playing statistic odds like AF, from all genuine and wannabe experts of all sorts or so-called biotech analysts or journalists.
Waste no time, get the message out; contact VIPs, particularly those who have had vast resources on disposal to compensate incompetent Dear Leader Linda Powers who has failed to have even a single VIP to get into the stock, because she is stink of various dimensions. Despite that, as I have accumulated and continually added to my position with my nose pinched, some big fish will come onboard considering the great prospect of DCVax platform in transferring the landscape of cancer treatment, and of ten or twenty bagger of stock appreciation potential, which is of much more grandeur than the stinkiness of the management!
Next time when voting is coming, use brain but no fear to vote.
Dear Linda Powers may still have a shred of opportunity to win some respect from me: find a big fish to back our stock and/or make a surprise announcement of a short-crushed news!
As I have said before, an investment cannot be said to be difficult if it would yield multiple bagger, let alone 10 or 20 bagger to an average self-claimed MB investor. The majority of MB investors are noise, appear or disappear frequently like a baby diaper change.
With the next six months, absolute silence is fine to me if she can deliver.
